SLC6A8 and cancer: Also of interest is a report of a novel CRT1 inhibitor, shown to suppress cancer growth and metastatic progression (Kurth et al., 2018), which implicates CRT1 in cancer and prompts a closer survey of cancer incidence among CTD patients.